Elemene, the essential oil of Curcuma wenyujin, inhibits osteogenic differentiation in ankylosing spondylitis

Joint Bone Spine

Volumn 82, Issue 2, 2015, Pages 100-103

  Zhou, Ying yan ^a,c   Liu, Hong Xiao ^a   Jiang, Nan ^a   Feng, Xing hua ^a   Feng, Xiao yan ^b   Zhang, He qiu ^b   Wu, Zhi kui ^a   Liang, Hui ying ^a   Jiang, Quan ^a   Chen, Peng ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Ankylosing spondylitis; BMP SMADs; Elemene; Fibroblasts; Ossification

Indexed keywords

BONE MORPHOGENETIC PROTEIN; ELEMENE; ESSENTIAL OIL; MESSENGER RNA; SMAD1 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; SESQUITERPENE; SMAD PROTEIN; TRANSCRIPTION FACTOR RUNX; VEGETABLE OIL;

ANKYLOSING SPONDYLITIS; ARTICLE; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; CURCUMA; CURCUMA WENYUJIN; CYTOPLASM; DIFFERENTIATION; DRUG STRUCTURE; FIBROBLAST CULTURE; FLUORESCENCE; HIP; HIP FRACTURE; HIP SURGERY; HUMAN; HUMAN CELL; JOINT CAPSULE; OSSIFICATION; OSTEOGENIC DIFFERENTIATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOTAL HIP PROSTHESIS; WESTERN BLOTTING; ADULT; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; DRUG EFFECTS; FIBROBLAST; HETEROTOPIC OSSIFICATION; HIP ARTHROPLASTY; MALE; METABOLISM; MIDDLE AGED; OSTEOBLAST; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

ADULT; ARTHROPLASTY, REPLACEMENT, HIP; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA SUBUNITS; CURCUMA; FIBROBLASTS; HIP JOINT; HUMANS; JOINT CAPSULE; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOBLASTS; PLANT OILS; SESQUITERPENES; SIGNAL TRANSDUCTION; SMAD PROTEINS; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 84924505291     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2014.05.004     Document Type: Article

References (20)

1. Kiltz U., Baraliakos X., Braun J. Spondyloarthritis - the novel concept. Dtsch Med Wochenschr 2012, 137:1745-1747.
2. Schett G. Bone formation versus bone resorption in ankylosing spondylitis. Adv Exp Med Biol 2009, 649:114-121.
3. Sieper J., Braun J., Rudwaleit M., et al. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002, 3:8-18.
4. Rutherford R.B., Moalli M., Franceschi R.T., et al. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng 2002, 8:441-452.
5. Ogawa M., LaRue A.C. Origin of fibroblast colony-forming units. Exp Hematol 2007, 35:1319-1320.
6. Nohe A., Hassel S., Ehrlich M., et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 2002, 277:5330-5338.
7. Braem K., Lories R.J. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models. Joint Bone Spine 2012, 79:243-248.
8. Heining E., Bhushan R., Paarmann P., et al. Spatial segregation of BMP/SMAD signaling affects osteoblast differentiation in C2C12 cells. PLoS One 2011, 6:e25163.
9. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
10. Nishimura R., Hata K., Harris S.E., et al. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 2002, 31:303-312.
11. Pharmacopeia Commission of PRC Pharmacopoeia of the People's Republic of China (English edition) 2000, 230. Chemical Industry Press, Beijing.
12. Feng X.H., Jiang Q., Liu H.X., et al. Clinical effect analysis of ankylosing spondylitis treated by Chinese medical syndrome differentiation. Zhongguo Zhong Xi Yi Jie He Za Zhi 2013, 33:1309-1314.
13. Wilson B., Abraham G., Manju V.S., et al. Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. J Ethnopharmacol 2005, 99:147-151.
14. Revathi S., Malathy N.S. Antibacterial activity of rhizome of Curcuma aromatica and partial purification of active compounds. Indian J Pharm Sci 2013, 75:732-735.
15. Xie C.Y., Yang W., Ying J., et al. B-cell lymphoma-2 over-expression protects. DELTA. Elemene-induced apoptosis in human lung carcinoma mucoepidermoid cells via a nuclear factor kappa B-related pathway. Biol Pharm Bull 2011, 34:1279-1286.
16. Wendling D., Claudepierre P. New bone formation in axial spondyloarthritis. Joint Bone Spine 2013, 80:454-458.
17. Braem K., Deroose C.M., Luyten F.P., et al. Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis. Arthritis Res Ther 2012, 14:R59.
18. Doran M.F., Brophy S., MacKay K., et al. Predictors of long-term outcome in ankylosing spondylitis. J Rheumatol 2003, 30:316-320.
19. van der Heijde D., Landewé R., Baraliakos X., et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008, 58:3063-3070.
20. van der Heijde D., Salonen D., Weissman B., et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 2009, 11:R127.